Sleep Smarts Quiz: Myth or Fact?

John Cronin, M.D., discusses how obstructive sleep apnea is a common yet often undiagnosed sleep disorder that disrupts breathing during sleep, leading to fatigue and health risks.

With 90% of OSA cases going undiagnosed, the high cost of in-lab studies remains a significant barrier. A new FDA-approved, noninvasive treatment option could change that.

Dionne Morgan, M.D., explains how sleep apnea often goes undiagnosed because its symptoms are common, subtle and easily overlooked.

Michael Howell, M.D., explains how sleep disorders like sleep apnea can increase the risk of heart disease, dementia and metabolic problems.

Improving sleep quality and screening for sleep apnea may help manage hypertension after menopause.

Christopher J. Allen, M.D., says our “tired but wired” lifestyles are fueling a sleep crisis across all ages.

New wearable features like blood pressure and oxygen tracking may uncover hidden health risks.

The study suggests that consistency in sleep timing — not total sleep — may play a key role in managing heart failure.

Weekend sleep pattern changes — including sleeping in and going to bed later — were linked to significantly more breathing interruptions in people with obstructive sleep apnea, potentially impacting diagnosis and treatment.

Practicing shankh blowing — a traditional respiratory exercise — may be a novel, low-cost way to help manage sleep apnea symptoms.

Alcohol, late dinners and light exposure are summer sleep saboteurs — Carleara Weiss, Ph.D., MS, RN, explains how to fight back.

Most people with sleep apnea go undiagnosed — Happy Ring aims to change that with an at-home test, virtual care and insurance-covered treatment options.

Oral devices, nerve stimulation, position therapy and medications may offer alternatives to traditional CPAP therapy.

A new study finds that teens who sleep earlier and longer perform better at tasks involving crystallized intelligence, picture vocabulary and oral reading recognition.

John Cronin, M.D., discusses how obstructive sleep apnea is a common yet often undiagnosed sleep disorder that disrupts breathing during sleep, leading to fatigue and health risks.

With 90% of OSA cases going undiagnosed, the high cost of in-lab studies remains a significant barrier. A new FDA-approved, noninvasive treatment option could change that.